Gcetam-Plus Tablet is a combination pharmaceutical formulation containing Citicoline 500 mg and Piracetam 800 mg, designed to enhance cognitive function and support neurological health. Citicoline, a neuroprotective agent, plays a crucial role in brain metabolism by promoting the synthesis of phosphatidylcholine, a key component of neuronal membranes, thereby aiding in the repair and maintenance of brain cells. It also facilitates the production of neurotransmitters such as acetylcholine, which are essential for memory and learning processes. Piracetam, a nootropic agent, improves neuronal communication by modulating neurotransmitter activity and enhancing cerebral blood flow and oxygen utilization. This synergistic combination is indicated for the management of cognitive impairments associated with cerebrovascular diseases, traumatic brain injury, dementia, and age-related memory decline. Gcetam-Plus Tablet may also be utilized as an adjunct in the treatment of neurological disorders characterized by cognitive dysfunction. The medication should be administered under medical supervision, with dosage tailored to individual patient needs. Common side effects are generally mild and may include gastrointestinal discomfort, headache, or nervousness. Contraindications include hypersensitivity to either component. Overall, Gcetam-Plus offers a therapeutic approach aimed at improving cognitive performance and neuroprotection.